Cor Vasa 2018, 60(6):e607-e614 | DOI: 10.1016/j.crvasa.2018.01.003

Should we fear infarct-like myocarditis?

Jan Duršpeka,*, Jan Baxab, Jakub Šedivýa, Daniel Rajdlc, Milan Hromádkaa, Jan Lhotskýa, Richard Rokytaa
a Cardiology Department, University Hospital and Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
b Department of Radiology, University Hospital in Pilsen, Pilsen, Czech Republic
c Institute of Clinical Biochemistry and Hematology, University Hospital in Pilsen, Pilsen, Czech Republic

Introduction: Infarct-like myocarditis is the most common presentation of acute myocarditis. A good prognosis is mentioned in the literature and several months of restricted physical activity is usually recommended.

Objectives: The aim of our study was to show the characteristic features and specificity of this particular presentation of myocarditis and to evaluate its prognosis, relative to physical activity, after hospital discharge.

Methodology: From 2012-2016, 73 patients with infarct-like myocarditis were hospitalized at the University Hospital of Pilsen and were evaluated by basic diagnostic parameters. Thirty-two patients from this group were involved in our prospective observational study where echocardiography (ECHO), magnetic resonance imaging (MRI) (including late gadolinium enhancement [LGE]), bicycle ergometry (BE) as well as troponin screening tests were regularly performed. One month after hospital discharge, all patients underwent bicycle ergometry without any load limitation. After the one-month follow-up, patients were allowed to increase physical exertion gradually to included job performance. None of the patients were professional athletes. During this observation time, 20 patients with different presentations of acute myocarditis were also admitted to hospital. These different presentations are discussed.

Results: None of the patients with infarct-like myocarditis had an early recurrence of the disease (i.e., within one year) or left ventricular (LV) systolic dysfunction (based on ECHO results). After one month, the LGE volume median had decreased by up to 53% and after six months it had decreased by up to 40% of the original value. After one and six months, hypersensitive troponin values were under the 99th percentile of the healthy population. The achieved exertion during BE, at the six-month follow-up (9.7 ± 2.2 METs) was statistically significantly better than after the one-month follow-up (8.9 ± 2.1 METs, p = 0.0023). On the last BE follow--ups (9.3 ± 2.1 METs), no significant change was seen (p = 0.2331). The average follow-up time was 2 years.

Conclusion: Infarct-like myocarditis has a specific feature that differs from other types of myocarditis. Infarct-like myocarditis has a good prognosis, which is independent of physical exertion starting one month after hospital discharge.

Keywords: Bicycle ergometry; Infarct like myocarditis; Late gadolinium enhancement; Magnetic resonance imaging; Prognosis

Received: December 11, 2017; Revised: January 6, 2018; Accepted: January 10, 2018; Published: December 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Duršpek J, Baxa J, Šedivý J, Rajdl D, Hromádka M, Lhotský J, Rokyta R. Should we fear infarct-like myocarditis? Cor Vasa. 2018;60(6):e607-614. doi: 10.1016/j.crvasa.2018.01.003.
Download citation

References

  1. C. Bock, A. Düchting, F. Utta, et al., Molecular phenotypes of human parvovirus B19 in patients with myocarditis, World Journal of Cardiology 6 (2014) 183-195. Go to original source... Go to PubMed...
  2. C. Schmidt-Lucke, T. Zobel, S. Schrepfer, et al., Impaired endothelial regeneration through human parvovirus B19-infected circulating angiogenic cells in patients with cardiomyopathy, Journal of Infectious Diseases 212 (2015) 1070-1081. Go to original source... Go to PubMed...
  3. S.A. Huber, C.J. Gauntt, P. Sakkinen, Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity, Advances in Virus Research 51 (1999) 35-68. Go to original source...
  4. K. Klingel, C. Hohenadl, A. Canu, et al., Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation, Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 314-318. Go to original source...
  5. A.L. Caforio, S. Pankuweit, E. Arbustini, et al., Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, European Heart Journal 34 (2013) 2636-2648. Go to original source... Go to PubMed...
  6. S.C. Koepsell, D.R. Anderson, S.J. Radio, Parvovirus is a bystander in adult myocarditis, Cardiovascular Pathology 21 (2012) 476-481. Go to original source... Go to PubMed...
  7. J. Krejčí, H. Poloczková, P. Hude, et al., Impact of inflammatory infiltration and viral genome presence in myocardium on the changes of echocardiographic parameters, Cor et Vasa 55 (2013) e333-e340. Go to original source...
  8. C. Hjalmarsson, J.Å. Liljeqvist, M. Lindh, et al., Parvovirus B19 in endomyocardial biopsy of patients with idiopathic dilated cardiomyopathy: foe or bystander?, Journal of Cardiac Failure 2018 Aug 10. pii: S1071-9164(18)30871-6. doi: 10.1016/j.cardfail.2018.07.466. [Epub ahead of print]. Go to original source... Go to PubMed...
  9. C. Bock, K. Klingel, R. Kandolf, et al., Human parvovirus B19-associated myocarditis, New England Journal of Medicine 362 (2010) 1248-1249. Go to original source... Go to PubMed...
  10. U. Kühl, M. Rohde, D. Lassner, et al., miRNA as activity marker in Parvo B19 associated heart disease, Herz 37 (2012) 637-643. Go to original source... Go to PubMed...
  11. D. Lassner, M. Rohde, C.S. Siegismund, et al., Myocarditis - personalized medicine by expanded endomyocardial biopsy diagnostics, World Journal of Cardiovascular Diseases 4 (2014) 325-340. Go to original source...
  12. H. Mahrholdt, A. Wagner, C.C. Deluigi, et al., Presentation, patterns of myocardial damage, and clinical course of viral myocarditis, Circulation 114 (2006) 1581-1590. Go to original source... Go to PubMed...
  13. R. Faletti, M. Gatti, I. Baralis, et al., Clinical and magnetic resonance evolution of "infarct-like" myocarditis, La Radiologia Medica 122 (2017) 273-279. Go to original source... Go to PubMed...
  14. J.C. Youn, H.S. Shim, J.S. Lee, et al., Detailed pathologic evaluation on endomyocardial biopsy provides long-term prognostic information in patients with acute myocarditis, Cardiovascular Pathology 23 (2014) 139-144. Go to original source... Go to PubMed...
  15. M. Anzini, M. Merlo, G. Sabbadini, et al., Long-term evolution and prognostic stratification of biopsy-proven active myocarditis, Circulation 128 (2013) 2384-2394. Go to original source... Go to PubMed...
  16. C. Basso, E. Carturan, D. Corrado, G. Thiene, Myocarditis and dilated cardiomyopathy in athletes: diagnosis, management and recommendations for sport activity, Cardiology Clinics 25 (2007) 423-429. Go to original source... Go to PubMed...
  17. A. Pelliccia, R. Fagard, H.H. Bjørnstad, et al., Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology, European Heart Journal 26 (2005) 1422-1445. Go to original source... Go to PubMed...
  18. J.A. Šedivý, J. Baxa, M. Hromádka, et al., Komplexní přístup ke sledování pacientů po akutní myokarditidě s využitím magnetické rezonance - předběžné výsledky, Česká radiologie 68 (4) (2014) 311-317.
  19. T. Caspar, M. Fichot, M. Ohana, et al., Late detection of left ventricular dysfunction using two-dimensional and three-dimensional speckle-tracking echocardiography in patients with history of nonsevere acute myocarditis, Journal of the American Society of Echocardiography 30 (2017) 756-762. Go to original source... Go to PubMed...
  20. T. Sturmberger, J. Niel, J. Aichinger, et al., Acute myocarditis with normal wall motion detected with 2D speckle tracking echocardiography, Echo Research and Practice 3 (2016) K15-K19. Go to original source... Go to PubMed...
  21. B. Baeßler, F. Schaarschmidt, A. Dick, et al., Diagnostic implications of magnetic resonance feature tracking derived myocardial strain parameters in acute myocarditis, European Journal of Radiology 85 (2016) 218-227. Go to PubMed...
  22. J.F. Hsiao, Y. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents, Journal of Cardiovascular Magnetic Resonance 16 (2014) 36. Go to original source... Go to PubMed...
  23. P. Lurz, I. Eitel, J. Adam, et al., Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis, JACC Cardiovascular Imaging 5 (2012) 513-524. Go to original source... Go to PubMed...
  24. M. Francone, C. Chimenti, N. Galea, et al., CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis, JACC Cardiovascular Imaging 7 (2014) 254-263. Go to original source... Go to PubMed...
  25. A.L. Caforio, G. Malipiero, R. Marcolongo, et al., Clinically suspected myocarditis with pseudo-infarct presentation: the role of endomyocardial biopsy, Journal of Thoracic Disease 9 (2017) 423-427. Go to original source... Go to PubMed...
  26. H. Chopra, D. Arangalage, C. Bouleti, et al., Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long- term outcome of patients after acute myocarditis, International Journal of Cardiology 212 (2016) 63-69. Go to original source... Go to PubMed...
  27. I. Kindermann, M. Kindermann, R. Kandolf, et al., Predictors of outcome in patients with suspected myocarditis, Circulation 11 (2008) 639-648. Go to original source... Go to PubMed...
  28. L.T. Cooper Jr., G.J. Berry, R. Shabetai, Idiopathic giant-cell myocarditis - natural history and treatment, New England Journal of Medicine 336 (1997) 1860-1866. Go to original source... Go to PubMed...
  29. R. Kandolin, J. Lehtonen, K. Salmenkivi, et al., Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression, Circulation: Heart Failure 6 (2013) 15-22. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.